shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Dec 3rd - Collaborative and Proactive Solutions at School: Moving from power and control to collaboration and problem solving [SickKids CCMH Learning Institute]
Dec 11th - ONTABA 2020 Annual Conference [ONTABA - Ontario Association for Behaviour Analysis]
May 1st - American Psychiatric Association 174th annual meeting, Los Angeles [APA]
Jun 17th - IARPP Conference 2021 - Expanding Our Clinical Experiences: The Spoken, Unspoken and Unspeakable in Relational Psychoanalysis and Psychotherapy [IARPP]
Jul 9th - 28th Annual OCD Conference [International OCD Foundation]
schools agencies and other institutional orders (click here)
Due to Covid-19, we are now open only for deliveries and pickups. Still free shipping across Canada for orders over $50. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
The Child Medication Fact Book for Psychiatric Practice
Feder, Joshua, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP
Carlat Publishing / Softcover / 2018-10-01 / 0997510684
Psychopharmacology / Child Psychiatry
reg price: $117.95 our price: $ 106.16
148 pages
In Stock (Ships within one business day)

The Child Medication Fact Book is a comprehensive reference guide covering all the important facts, from cost to pharmacokinetics, about the most commonly prescribed medications in child and adolescent psychiatry. Composed of single-page, reader-friendly fact sheets and quick scan medication tables, this book offers guidance, clinical pearls, and bottom line assessments of more than 70 of the most common medications you use and are asked about in your practice. Versions of this book can be purchased with an 8-credit CME online post-test.

Featuring:

• The latest on new medications such as Adzenys XR-ODT, Dyanavel XR, and Evekeo
• 70 medication fact sheets including complementary treatments
• 10 quick-scan medication reference tables
• 9 appendices including informed consent guidelines

Get the information you need at a glance:

• Off-label uses
• Dosage and generic availability
• Mechanism of action
• Cost information
• Bottom line impression

Review Quotes:

"Practical, thorough, and easy to use--a must for all prescribers!"
--Fred R. Volkmar, MD
Child Study Center, Yale University School of Medicine

"From one of the most trusted names in psychopharmacology comes this user friendly, practical, and extremely useful guide to the treatment of child and adolescent mental illness. Highly recommended for both trainees and experienced practitioners alike. I myself will be referring back to this book for years to come."
--Jess P. Shatkin, MD, MPH
Professor of Child and Adolescent Psychiatry and Pediatrics, NYU School of Medicine

"This is a very helpful and user-friendly guidebook. The information fits on one page with bullets rather than unnecessary verbiage. FDA indications are noted as well as off label uses, evidence/research is cited (including negative studies). Dose guidelines and side effects are easy to spot. Medications included go beyond what the usual psychopharmacology book include. Altogether, this book packs a real punch!"
--Gabrielle A. Carlson, MD
Professor of Psychiatry and Pediatrics, Stony Brook University School of Medicine

Table of Contents:

Introduction
General Tips

ADHD Medications
Amphetamine (Adzenys XR-ODT, Dyanavel XR, Evekeo)
Atomoxetine (Strattera) ¬¬
Clonidine (Catapres, Kapvay)
Dexmethylphenidate (Focalin)
Dextroamphetamine (Dexedrine)
Guanfacine (Intuniv, Tenex)
Lisdexamfetamine (Vyvanse)
Methamphetamine (Desoxyn)
Methylphenidate IR (Ritalin)
Methylphenidate ER (Concerta, Ritalin-SR and LA)
Methylphenidate Transdermal (Daytrana)
Mixed Amphetamine Salts (Adderall)
Antidepressants
Bupropion (Wellbutrin)
Citalopram (Celexa)
Desvenlafaxine (Pristiq)
Duloxetine (Cymbalta)
Escitalopram (Lexapro)
Fluoxetine (Prozac)
Fluvoxamine (Luvox)
Mirtazapine (Remeron)
Paroxetine (Paxil, Pexeva)
Selegiline Transdermal (EMSAM)
Sertraline (Zoloft)
Trazodone
Tricyclic Antidepressants (TCAs)
Venlafaxine (Effexor XR)
Antipsychotics
Aripiprazole (Abilify)
Asenapine (Saphris)
Chlorpromazine (Thorazine)
Clozapine (Clozaril)
Haloperidol (Haldol)
Lurasidone (Latuda)
Olanzapine (Zyprexa)
Paliperidone (Invega)
Perphenazine (Trilafon)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ziprasidone (Geodon)
Long-Acting Injectable (LAI) Antipsychotics

Anxiolytics and Hypnotics
Antihistamines (Diphenhydramine, Doxylamine, Hydroxyzine)
Buspirone (BuSpar)
Clonazepam (Klonopin)
Lorazepam (Ativan)
Prazosin (Minipress)
Propranolol (Inderal)

Complementary Treatments
L-Methylfolate (Deplin)
Magnesium
Melatonin
N-Acetylcysteine (NAC)
Omega-3 Fatty Acids (Fish Oil)
S-Adenosyl-L-Methionine (SAMe)
St. John's Wort
Vitamin D

Mood Stabilizers
Carbamazepine (Tegretol)
Lamotrigine (Lamictal)
Lithium (Lithobid)
Oxcarbazepine (Trileptal)
Valproic Acid (Depakote)

Substance Use Medications
Acamprosate (Campral)
Buprenorphine (Buprenex, Probuphine, Sublocade)
Buprenorphine/Naloxone (Suboxone)
Disulfiram (Antabuse)
Methadone (Methadose)
Naloxone (Evzio, Narcan Nasal Spray)
Naltrexone (ReVia, Vivitrol)
Nicotine Gum/Lozenge (Nicorette)
Nicotine Inhaled (Nicotrol Inhaler)
Nicotine Nasal Spray (Nicotrol NS)
Nicotine Patch (Nicoderm CQ)
Varenicline (Chantix)

Appendices
Appendix A: Blood Pressure Parameters for Children
Appendix B: Growth and Body Mass Index Charts
Appendix C: Abnormal Involuntary Movement Scale (AIMS)
Appendix D: Guidelines for Informed Consent
Appendix E: Drug Interactions in Psychiatry
Appendix F: Schedules of Controlled Substances
Appendix G: Lab Monitoring for Psychiatric Medications
Appendix H: Pharmacogenetic Testing Recommendations
Appendix I: Pregnancy and Lactation Risk Information

List of Tables
Table 1: ADHD Medications
Table 2: Antidepressants
Table 3: First-Generation Antipsychotics
Table 4: Second-Generation Antipsychotics
Table 5: Long-Acting Injectable Antipsychotics
Table 6: Anxiolytics and Hypnotics
Table 6.1: Benzodiazepine Dosage Equivalencies
Table 7: Complementary Treatments
Table 8: Mood Stabilizers
Table 9: Substance Use/Dependence Medications

Index

About the Authors:

Joshua D. Feder, MD, is a child psychiatrist active in clinical practice, research, and advocacy. He serves as editor-in-chief of The Carlat Child Psychiatry Report and associate clinical professor at University of California at San Diego School of Medicine.

Elizabeth Tien, MD, is a child, adolescent, and adult psychiatrist specializing in the clinical care of underserved communities and the implementation and delivery of collaborative care and adult and adolescent psychiatrist at Maimonides Medical Center.

Talia Puzantian, PharmD, BCPP, is an associate professor at Keck Graduate Institute School of Pharmacy in Claremont, CA and the deputy editor of The Carlat Psychiatry Report.

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / 12-5 Sun (EST)

search
Click here to read previous issues.
authors
Puzantian, Talia
other lists
Carlat Publishing
Child Psychiatry
Psychopharmacology